EXELON CORP (EXC) Fundamental Analysis & Valuation

NASDAQ:EXC • US30161N1019

Current stock price

49.33 USD
+0.45 (+0.92%)
At close:
49.33 USD
0 (0%)
After Hours:

This EXC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. EXC Profitability Analysis

1.1 Basic Checks

  • In the past year EXC was profitable.
  • EXC had a positive operating cash flow in the past year.
  • Each year in the past 5 years EXC has been profitable.
  • In the past 5 years EXC always reported a positive cash flow from operatings.
EXC Yearly Net Income VS EBIT VS OCF VS FCFEXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B -4B 6B 8B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 2.37%, EXC is doing worse than 70.21% of the companies in the same industry.
  • The Return On Equity of EXC (9.61%) is comparable to the rest of the industry.
  • The Return On Invested Capital of EXC (4.25%) is comparable to the rest of the industry.
  • EXC had an Average Return On Invested Capital over the past 3 years of 3.93%. This is in line with the industry average of 4.52%.
  • The 3 year average ROIC (3.93%) for EXC is below the current ROIC(4.25%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.37%
ROE 9.61%
ROIC 4.25%
ROA(3y)2.31%
ROA(5y)2.1%
ROE(3y)9.26%
ROE(5y)8.3%
ROIC(3y)3.93%
ROIC(5y)3.42%
EXC Yearly ROA, ROE, ROICEXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • The Profit Margin of EXC (11.41%) is worse than 68.09% of its industry peers.
  • In the last couple of years the Profit Margin of EXC has grown nicely.
  • EXC has a Operating Margin (21.21%) which is in line with its industry peers.
  • EXC's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 64.28%, EXC perfoms like the industry average, outperforming 53.19% of the companies in the same industry.
  • In the last couple of years the Gross Margin of EXC has remained more or less at the same level.
Industry RankSector Rank
OM 21.21%
PM (TTM) 11.41%
GM 64.28%
OM growth 3Y6.85%
OM growth 5Y20.15%
PM growth 3Y0.11%
PM growth 5Y13.94%
GM growth 3Y-1.36%
GM growth 5Y1.26%
EXC Yearly Profit, Operating, Gross MarginsEXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

2

2. EXC Health Analysis

2.1 Basic Checks

  • EXC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, EXC has more shares outstanding
  • EXC has more shares outstanding than it did 5 years ago.
  • EXC has a better debt/assets ratio than last year.
EXC Yearly Shares OutstandingEXC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
EXC Yearly Total Debt VS Total AssetsEXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • EXC has an Altman-Z score of 0.78. This is a bad value and indicates that EXC is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.78, EXC is in line with its industry, outperforming 44.68% of the companies in the same industry.
  • EXC has a Debt/Equity ratio of 1.68. This is a high value indicating a heavy dependency on external financing.
  • EXC has a worse Debt to Equity ratio (1.68) than 63.83% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.68
Debt/FCF N/A
Altman-Z 0.78
ROIC/WACC0.67
WACC6.38%
EXC Yearly LT Debt VS Equity VS FCFEXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B 30B 40B

2.3 Liquidity

  • EXC has a Current Ratio of 0.92. This is a bad value and indicates that EXC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • EXC has a better Current ratio (0.92) than 65.96% of its industry peers.
  • EXC has a Quick Ratio of 0.92. This is a bad value and indicates that EXC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.84, EXC is in the better half of the industry, outperforming 65.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.84
EXC Yearly Current Assets VS Current LiabilitesEXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

4

3. EXC Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 10.40% over the past year.
  • EXC shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.04% yearly.
  • EXC shows a small growth in Revenue. In the last year, the Revenue has grown by 5.34%.
  • Measured over the past years, EXC shows a decrease in Revenue. The Revenue has been decreasing by -5.99% on average per year.
EPS 1Y (TTM)10.4%
EPS 3Y6.89%
EPS 5Y-3.04%
EPS Q2Q%-7.81%
Revenue 1Y (TTM)5.34%
Revenue growth 3Y8.34%
Revenue growth 5Y-5.99%
Sales Q2Q%-1.08%

3.2 Future

  • The Earnings Per Share is expected to grow by 6.25% on average over the next years.
  • EXC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.80% yearly.
EPS Next Y4.29%
EPS Next 2Y5.57%
EPS Next 3Y6.08%
EPS Next 5Y6.25%
Revenue Next Year4.06%
Revenue Next 2Y3.7%
Revenue Next 3Y3.52%
Revenue Next 5Y3.8%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EXC Yearly Revenue VS EstimatesEXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B
EXC Yearly EPS VS EstimatesEXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

2

4. EXC Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 17.87 indicates a rather expensive valuation of EXC.
  • EXC's Price/Earnings is on the same level as the industry average.
  • When comparing the Price/Earnings ratio of EXC to the average of the S&P500 Index (25.51), we can say EXC is valued slightly cheaper.
  • A Price/Forward Earnings ratio of 17.14 indicates a rather expensive valuation of EXC.
  • EXC's Price/Forward Earnings is on the same level as the industry average.
  • When comparing the Price/Forward Earnings ratio of EXC to the average of the S&P500 Index (22.76), we can say EXC is valued slightly cheaper.
Industry RankSector Rank
PE 17.87
Fwd PE 17.14
EXC Price Earnings VS Forward Price EarningsEXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 61.70% of the companies in the same industry are more expensive than EXC, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.25
EXC Per share dataEXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates EXC does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)4.17
PEG (5Y)N/A
EPS Next 2Y5.57%
EPS Next 3Y6.08%

7

5. EXC Dividend Analysis

5.1 Amount

  • EXC has a Yearly Dividend Yield of 3.47%.
  • Compared to an average industry Dividend Yield of 2.86, EXC pays a bit more dividend than its industry peers.
  • EXC's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 3.47%

5.2 History

  • The dividend of EXC has a limited annual growth rate of 0.82%.
  • EXC has been paying a dividend for at least 10 years, so it has a reliable track record.
  • EXC has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)0.82%
Div Incr Years3
Div Non Decr Years10
EXC Yearly Dividends per shareEXC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 58.42% of the earnings are spent on dividend by EXC. This is a bit on the high side, but may be sustainable.
  • The dividend of EXC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP58.42%
EPS Next 2Y5.57%
EPS Next 3Y6.08%
EXC Yearly Income VS Free CF VS DividendEXC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B -4B
EXC Dividend Payout.EXC Dividend Payout, showing the Payout Ratio.EXC Dividend Payout.PayoutRetained Earnings

EXC Fundamentals: All Metrics, Ratios and Statistics

EXELON CORP

NASDAQ:EXC (4/2/2026, 4:30:02 PM)

After market: 49.33 0 (0%)

49.33

+0.45 (+0.92%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryElectric Utilities
Earnings (Last)02-12
Earnings (Next)04-29
Inst Owners92.78%
Inst Owner Change3.98%
Ins Owners0.09%
Ins Owner Change5.84%
Market Cap50.46B
Revenue(TTM)24.26B
Net Income(TTM)2.77B
Analysts68.46
Price Target51.14 (3.67%)
Short Float %3.91%
Short Ratio4.26
Dividend
Industry RankSector Rank
Dividend Yield 3.47%
Yearly Dividend1.59
Dividend Growth(5Y)0.82%
DP58.42%
Div Incr Years3
Div Non Decr Years10
Ex-Date03-02
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.2%
Min EPS beat(2)6.79%
Max EPS beat(2)9.62%
EPS beat(4)4
Avg EPS beat(4)6.33%
Min EPS beat(4)3.88%
Max EPS beat(4)9.62%
EPS beat(8)7
Avg EPS beat(8)6.42%
EPS beat(12)10
Avg EPS beat(12)4.87%
EPS beat(16)11
Avg EPS beat(16)3.48%
Revenue beat(2)1
Avg Revenue beat(2)1.39%
Min Revenue beat(2)-0.48%
Max Revenue beat(2)3.25%
Revenue beat(4)2
Avg Revenue beat(4)0.9%
Min Revenue beat(4)-0.48%
Max Revenue beat(4)3.25%
Revenue beat(8)6
Avg Revenue beat(8)4.72%
Revenue beat(12)10
Avg Revenue beat(12)8.33%
Revenue beat(16)13
Avg Revenue beat(16)7.95%
PT rev (1m)1.26%
PT rev (3m)2.04%
EPS NQ rev (1m)0.3%
EPS NQ rev (3m)-0.08%
EPS NY rev (1m)0.28%
EPS NY rev (3m)0.41%
Revenue NQ rev (1m)-1.76%
Revenue NQ rev (3m)-1.2%
Revenue NY rev (1m)0.15%
Revenue NY rev (3m)0.59%
Valuation
Industry RankSector Rank
PE 17.87
Fwd PE 17.14
P/S 2.08
P/FCF N/A
P/OCF 8.07
P/B 1.75
P/tB 2.28
EV/EBITDA 11.25
EPS(TTM)2.76
EY5.59%
EPS(NY)2.88
Fwd EY5.83%
FCF(TTM)-2.22
FCFYN/A
OCF(TTM)6.11
OCFY12.39%
SpS23.72
BVpS28.15
TBVpS21.67
PEG (NY)4.17
PEG (5Y)N/A
Graham Number41.81
Profitability
Industry RankSector Rank
ROA 2.37%
ROE 9.61%
ROCE 4.84%
ROIC 4.25%
ROICexc 4.27%
ROICexgc 4.55%
OM 21.21%
PM (TTM) 11.41%
GM 64.28%
FCFM N/A
ROA(3y)2.31%
ROA(5y)2.1%
ROE(3y)9.26%
ROE(5y)8.3%
ROIC(3y)3.93%
ROIC(5y)3.42%
ROICexc(3y)3.95%
ROICexc(5y)3.44%
ROICexgc(3y)4.23%
ROICexgc(5y)3.69%
ROCE(3y)4.53%
ROCE(5y)3.96%
ROICexgc growth 3Y7.73%
ROICexgc growth 5Y15.41%
ROICexc growth 3Y8.27%
ROICexc growth 5Y15.33%
OM growth 3Y6.85%
OM growth 5Y20.15%
PM growth 3Y0.11%
PM growth 5Y13.94%
GM growth 3Y-1.36%
GM growth 5Y1.26%
F-Score6
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 1.68
Debt/FCF N/A
Debt/EBITDA 5.51
Cap/Depr 234.12%
Cap/Sales 35.16%
Interest Coverage 2.55
Cash Conversion 71.17%
Profit Quality N/A
Current Ratio 0.92
Quick Ratio 0.84
Altman-Z 0.78
F-Score6
WACC6.38%
ROIC/WACC0.67
Cap/Depr(3y)214.26%
Cap/Depr(5y)190.09%
Cap/Sales(3y)33.36%
Cap/Sales(5y)36.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.4%
EPS 3Y6.89%
EPS 5Y-3.04%
EPS Q2Q%-7.81%
EPS Next Y4.29%
EPS Next 2Y5.57%
EPS Next 3Y6.08%
EPS Next 5Y6.25%
Revenue 1Y (TTM)5.34%
Revenue growth 3Y8.34%
Revenue growth 5Y-5.99%
Sales Q2Q%-1.08%
Revenue Next Year4.06%
Revenue Next 2Y3.7%
Revenue Next 3Y3.52%
Revenue Next 5Y3.8%
EBIT growth 1Y19.4%
EBIT growth 3Y15.76%
EBIT growth 5Y12.95%
EBIT Next Year90.24%
EBIT Next 3Y30.39%
EBIT Next 5Y20.94%
FCF growth 1Y-48.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.3%
OCF growth 3Y8.7%
OCF growth 5Y8.11%

EXELON CORP / EXC Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EXELON CORP?

ChartMill assigns a fundamental rating of 4 / 10 to EXC.


Can you provide the valuation status for EXELON CORP?

ChartMill assigns a valuation rating of 2 / 10 to EXELON CORP (EXC). This can be considered as Overvalued.


Can you provide the profitability details for EXELON CORP?

EXELON CORP (EXC) has a profitability rating of 5 / 10.


What is the financial health of EXELON CORP (EXC) stock?

The financial health rating of EXELON CORP (EXC) is 2 / 10.


Can you provide the expected EPS growth for EXC stock?

The Earnings per Share (EPS) of EXELON CORP (EXC) is expected to grow by 4.29% in the next year.